Cutaneous squamous cell carcinoma (cSCC) is increasing in incidence and is now ranked as the second most common skin cancer world-wide.
1 When excised surgically with free margins, the prognosis is mostly good,
2 but it is poor if metastasis has occurred.
3- 5 Several staging systems for cSCC have been developed to predict patients’ risk of metastasis and to individualize treatment and the follow-up schedule (Figure 1).
6- 9 In 2011, the American Joint Committee on Cancer (AJCC) published the 7th edition of its staging system (
AJCC 7),
6 which is based on tumor diameter and several risk features, including tumor depth, perineural invasion, primary site, and degree of differentiation as well as bone invasion. Although widely used, the
AJCC 7 staging system has been criticized for low specificity and for being too complicated for use in clinical practice.
10 Other staging systems have been introduced by Breuninger and coworkers (hereinafter, Breuninger system),
8 primarily based on clinical tumor size and histological tumor thickness, and by a research group at the Brigham and Women’s Hospital (BHW),
9 with 4 risk features defining the risk categories. Recently, an 8th edition of the AJCC staging system, to be used for cSCCs in the head-and-neck area only, has been introduced and will be implemented in 2018.
7